Yüklüyor......
Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression
5-Fluorouracil (5-FU) is a key drug for the treatment of esophageal squamous cell carcinoma (ESCC); however, resistance to it remains a critical limitation to its clinical use. To clarify the mechanisms of 5-FU resistance of ESCC, we originally established 5-FU-resistant ESCC cells, TE-5R, by step-w...
Kaydedildi:
Yayımlandı: | Am J Cancer Res |
---|---|
Asıl Yazarlar: | , , , , , , , , , , , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
e-Century Publishing Corporation
2015
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4568778/ https://ncbi.nlm.nih.gov/pubmed/26396918 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|